Dr. Mehlika Hazar Rethinam is a PhD-trained biomedical scientist dedicated to advancing precision oncology. She earned her PhD in Biomedical Science and Molecular Biology from the University of Queensland, followed by a postdoctoral fellowship at Harvard Medical School, where she pioneered liquid biopsy techniques for personalised cancer treatment. Her research has been featured in leading journals such as Nature Medicine and Cancer Discovery. As Global Medical Lead at Roche Diagnostics Solutions, Dr. Rethinam drives medical education and KOL engagement, leveraging her expertise to support innovation and improve patient outcomes. Her passion for translating science into impactful solutions makes her an inspiring speaker.